Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-260500
Filing Date
2025-10-31
Accepted
2025-10-31 13:48:30
Documents
4
Period of Report
2025-10-31

Document Format Files

Seq Description Document Type Size
1 6-K d915807d6k.htm 6-K 8743
2 EX-99.1 d915807dex991.htm EX-99.1 21942
3 GRAPHIC g915807g1029223527709.jpg GRAPHIC 2601
4 GRAPHIC g915807g77a40.jpg GRAPHIC 4876
  Complete submission text file 0001193125-25-260500.txt   42357
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 251439733
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)